Evidence map›Paper›PMID 20598119›Full record

ArticleAIDS research and therapy2010

Nef-specific CD45RA+ CD8+ T cells secreting MIP-1beta but not IFN-gamma are associated with nonprogressive HIV-1 infection.

Claudia J Dembek, Sarah Kutscher, Silvia Heltai, Simone Allgayer, Priscilla Biswas, Silvia Ghezzi, Elisa Vicenzi, Dieter Hoffmann, Peter Reitmeir, Giuseppe Tambussi and 13 more

Abstract read
In one paragraph

Article in AIDS research and therapy, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Claudia J DembekInstitute of Virology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany.
Sarah KutscherInstitute of Virology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany.
Silvia HeltaiHuman Virology Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.
Simone AllgayerClinical Cooperation Group "Immune Monitoring", Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany.
Priscilla BiswasLaboratory of Clinical Immunology, San Raffaele Scientific Institute, 20132 Milan, Italy.
Silvia GhezziViral Pathogens and Biosafety Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.
Elisa VicenziViral Pathogens and Biosafety Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.
Dieter HoffmannInstitute of Virology, Technische Universität München, 81675 Munich, Germany.
Peter ReitmeirInstitute of Health Economics and Health Care Management, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany.
Giuseppe TambussiDepartment of Infectious Diseases, San Raffaele Scientific Institute, 20132 Milan, Italy.
Johannes R BognerDepartment of Infectious Diseases, Medizinische Poliklinik, Ludwig Maximilians Universität, 80336 Munich, Germany.
Paolo LussoHuman Virology Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.
Hans-J StellbrinkInfektionsmedizinisches Centrum Hamburg ICH, 20146 Hamburg, Germany.
Elena Santagostino"A. Bianchi Bonomi" Haemophilia and Thrombosis Center, University of Milan, 20122 Milan, Italy.
Thomas VollbrechtDepartment of Infectious Diseases, Medizinische Poliklinik, Ludwig Maximilians Universität, 80336 Munich, Germany.
Frank D GoebelDepartment of Infectious Diseases, Medizinische Poliklinik, Ludwig Maximilians Universität, 80336 Munich, Germany.
Ulrike ProtzerInstitute of Virology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany.
Rika DraenertDepartment of Infectious Diseases, Medizinische Poliklinik, Ludwig Maximilians Universität, 80336 Munich, Germany.
Marco TinelliDivision of Infectious and Tropical Diseases, Hospital of Lodi, 26866 Lodi, Italy.
Guido PoliAIDS Immunopathogenesis Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.
Volker ErfleInstitute of Virology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany.
Mauro Malnati *Human Virology Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.
Antonio Cosma *Institute of Virology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLong-term survival of HIV-1 infected individuals is usually achieved by continuous administration of combination antiretroviral therapy (ART). An exception to this scenario is represented by HIV-1 infected nonprogressors (NP) which maintain relatively high circulating CD4+ T cells without clinical symptoms for several years in the absence of ART. Several lines of evidence indicate an important role of the T-cell response in the modulation of HIV-1 infection during the acute and chronic phase of the disease.

resultsWe analyzed the functional and the differentiation phenotype of Nef- and Tat-specific CD8+ T cells in a cohort of HIV-1 infected NP in comparison to progressors, ART-treated seropositive individuals and individuals undergoing a single cycle of ART interruption. We observed that a distinctive feature of NP is the presence of Nef-specific CD45RA+ CD8+ T cells secreting MIP-1beta but not IFN-gamma. This population was present in 7 out of 11 NP. CD45RA+ IFN-gammaneg MIP-1beta+ CD8+ T cells were not detected in HIV-1 infected individuals under ART or withdrawing from ART and experiencing a rebounding viral replication. In addition, we detected Nef-specific CD45RA+ IFN-gammaneg MIP-1beta+ CD8+ T cells in only 1 out of 10 HIV-1 infected individuals with untreated progressive disease.

conclusionThe novel antigen-specific CD45RA+ IFN-gammaneg MIP-1beta+ CD8+ T cell population represents a new candidate marker of long-term natural control of HIV-1 disease progression and a relevant functional T-cell subset in the evaluation of the immune responses induced by candidate HIV-1 vaccines.

Identifiers

PMID20598119
PMCPMC2909146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.